2023-02-24 18:56 | CC:PAS | Pascal Biosciences Inc | 0.015 | SEDAR MD & A815 | SEDAR MD & A |
2023-02-24 18:54 | CC:PAS | Pascal Biosciences Inc | 0.015 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
2023-02-15 11:29 | CC:PAS | Pascal Biosciences Inc | 0.015 | News Release200 | Pascal firms up acquisition of THC Essentials assets |
2023-02-03 11:36 | CC:PAS | Pascal Biosciences Inc | 0.015 | SEDAR Early Warning Report807 | SEDAR Early Warning Report |
2023-02-03 10:25 | CC:PAS | Pascal Biosciences Inc | 0.015 | News Release200 | Pascal investor McDermid acquires 78,000 shares |
2022-12-09 17:00 | CC:PAS | Pascal Biosciences Inc | 0.015 | News Release200 | Pascal proposes delisting from TSX-V, listing on CSE |
2022-12-07 20:09 | CC:PAS | Pascal Biosciences Inc | 0.015 | Halt Trading170 | Pascal Biosciences to remain halted |
2022-12-06 12:20 | CC:PAS | Pascal Biosciences Inc | 0.015 | News Release200 | Pascal Biosciences signs term sheet for THC Essentials |
2022-12-05 11:07 | CC:PAS | Pascal Biosciences Inc | 0.02 | Halt Trading170 | Pascal Biosciences halted at 8:04 a.m. PT |
2022-10-12 17:48 | CC:PAS | Pascal Biosciences Inc | 0.02 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2022-10-12 17:48 | CC:PAS | Pascal Biosciences Inc | 0.02 | SEDAR MD & A815 | SEDAR MD & A |
2022-07-27 19:44 | CC:PAS | Pascal Biosciences Inc | 0.02 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2022-07-27 19:44 | CC:PAS | Pascal Biosciences Inc | 0.02 | SEDAR MD & A815 | SEDAR MD & A |
2022-06-14 07:08 | CC:PAS | Pascal Biosciences Inc | 0.045 | News Release200 | Pascal to focus on consulting, contract research |
2022-04-29 22:34 | CC:PAS | Pascal Biosciences Inc | 0.055 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2022-04-29 22:34 | CC:PAS | Pascal Biosciences Inc | 0.055 | SEDAR MD & A815 | SEDAR MD & A |
2022-04-21 09:03 | CC:PAS | Pascal Biosciences Inc | 0.065 | News Release200 | Pascal notes patent filing for CBD COVID-19 treatment |
2022-03-25 20:53 | CC:PAS | Pascal Biosciences Inc | 0.085 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
2022-03-25 20:53 | CC:PAS | Pascal Biosciences Inc | 0.085 | SEDAR MD & A815 | SEDAR MD & A |